Authors: Barak, V Nisman, B Hubert, A Lyass, O Kaduri, L Peretz, T

Citation: V. Barak et al., Prognostic efficacy of TPS in breast cancer, J TUMOR M, 15(3), 2000, pp. 171-176

Authors: Nisman, B Heching, N Barak, V

Citation: B. Nisman et al., Serum tumor markers in resectable and non-resectable non-small cell lung cancer, J TUMOR M, 15(3), 2000, pp. 195-207

Authors: Barak, V Acker, M Nisman, B Kalickman, I Abrahamov, A Zimran, A Yatziv, S

Citation: V. Barak et al., Cytokines in Gaucher's disease, EUR CYTOKIN, 10(2), 1999, pp. 205-210

Authors: Barak, V Nisman, B Polliack, A

Citation: V. Barak et al., The tumor necrosis factor family and correlation with disease activity andresponse to treatment in hairy cell leukemia, EUR J HAEMA, 62(2), 1999, pp. 71-75

Authors: Nisman, B Amir, G Lafair, J Heching, N Lyass, O Peretz, T Barak, V

Citation: B. Nisman et al., Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer, ANTICANC R, 19(4C), 1999, pp. 3549-3552

Authors: Barak, V Kalickman, I Nisman, B Farbstein, H Fridlender, ZG Baider, L Kaplan, A Stephanos, S Peretz, T

Citation: V. Barak et al., Changes in cytokine production of breast cancer patients treated with interferons, CYTOKINE, 10(12), 1998, pp. 977-983